Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Association of blood eicosapentaenoic acid levels with intracerebral hemorrhage during the COVID-19 pandemic: preliminary experience from a single-center in Japan

Fig. 1

Comparison of serum omega-3 polyunsaturated fatty acid levels between ICH patients before and during the COVID-19 pandemic. Serum levels of EPA (63.74 ± 43.29 μg/ml vs. 31.87 ± 12.93 μg/ml), DHA (113.99 ± 58.58 μg/ml vs. 93.38 ± 31.91 μg/ml), EPA + DHA (175.42 ± 91.8 μg/ml vs. 125.25 ± 41.69 μg/ml), EPA/AA ratio (0.33 ± 0.24 vs. 0.20 ± 0.07), DHA/AA ratio (0.62 ± 0.35 vs. 0.60 ± 0.22), and EPA + DHA/AA ratio (0.96 ± 0.53 vs. 0.80 ± 0.27 in ICH patients before and during the COVID-19 pandemic, respectively (n = 87). The Mann-Whitney U test was used for comparison. ICH = intracerebral hemorrhage; EPA = eicosapentaenoic acid; DHA = docosahexaenoic acid; AA = arachidonic acid

Back to article page